MMED (MiniMed Group, Inc. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by MMED officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-04 | Que Dallara | Chief Executive Officer | F | — | — |
| 2026-08-04 | Ali Dianaty | EVP Ch. Prod. & Tech Officer | F | — | — |
| 2026-08-04 | Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | F | — | — |
| 2026-07-29 | Chad Spooner | EVP, Chief Financial Officer | F | — | — |
| 2026-07-29 | Gillian Chandrasena | SVP, Chief HR Officer | F | — | — |
| 2026-07-06 | Gillian Chandrasena | SVP, Chief HR Officer | A | — | — |
| 2026-07-06 | John Gyurci | VP, Chief Accounting Officer | A | — | — |
| 2026-07-06 | Ali Dianaty | See Remarks | A | — | — |
| 2026-07-06 | Que Dallara | Chief Executive Officer | A | — | — |
| 2026-07-06 | Chad Spooner | EVP, Chief Financial Officer | A | — | — |
| 2026-07-06 | Courtney Nelson Wills | SVP, Gen. Counsel, Corp. Sec. | A | — | — |
| 2026-03-27 | Que Dallara | Chief Executive Officer | F | — | — |
| 2026-03-13 | John Gyurci | See Remarks | A | — | — |
| 2026-03-13 | Que Dallara | Chief Executive Officer | A | — | — |
| 2026-03-13 | Gillian Chandrasena | See Remarks | A | — | — |
| 2026-03-13 | Chad Spooner | EVP, Chief Financial Officer | A | — | — |
| 2026-03-13 | Courtney Nelson Wills | See Remarks | A | — | — |
| 2026-03-13 | Ali Dianaty | See Remarks | A | — | — |
| 2026-03-11 | GLENN A EISENBERG | Director | A | — | — |
| 2026-03-11 | Kevin E Lofton | Director | A | — | — |
| 2026-03-11 | D KEITH GROSSMAN | Director | A | — | — |
| 2026-03-11 | Ali Dianaty | See Remarks | A | — | — |
| 2026-03-11 | Que Dallara | Chief Executive Officer | A | — | — |
| 2026-03-11 | Timothy A Wicks | Director | A | — | — |
| 2026-03-11 | Chad Spooner | EVP, Chief Financial Officer | A | — | — |
| 2026-03-11 | John Gyurci | See Remarks | A | — | — |
| 2026-03-11 | Courtney Nelson Wills | See Remarks | A | — | — |
| 2026-03-11 | Gillian Chandrasena | See Remarks | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Chief Executive Officer | 884,749 | — |
| — | EVP, Chief Financial Officer | 362,707 | — |
| — | EVP Ch. Prod. & Tech Officer | 315,158 | — |
| — | SVP, Chief HR Officer | 172,745 | — |
| — | SVP, Gen. Counsel, Corp. Sec. | 136,384 | — |
| — | VP, Chief Accounting Officer | 39,941 | — |
| — | Director | 27,778 | — |
| — | Director | 13,889 | — |
| — | Director | 13,889 | — |
| — | Director | 13,889 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the MMED quote page; the site-wide leaderboard is on the insider transactions hub.